Toho Holdings Co., Ltd. (8129.T)
JPY 4236.0
(0.09%)
JPY 4236.0
(0.09%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1476.71 Billion JPY | 6.35% |
| 2022 | 1388.56 Billion JPY | 9.67% |
| 2021 | 1266.17 Billion JPY | 4.61% |
| 2020 | 1210.33 Billion JPY | -4.23% |
| 2019 | 1263.76 Billion JPY | 3.4% |
| 2018 | 1222.19 Billion JPY | 0.73% |
| 2017 | 1213.32 Billion JPY | -1.45% |
| 2016 | 1231.17 Billion JPY | -5.9% |
| 2015 | 1308.35 Billion JPY | 12.58% |
| 2014 | 1162.11 Billion JPY | -2.31% |
| 2013 | 1189.62 Billion JPY | 4.32% |
| 2012 | 1140.35 Billion JPY | 2.91% |
| 2011 | 1108.14 Billion JPY | 4.58% |
| 2010 | 1059.58 Billion JPY | 5.73% |
| 2009 | 1002.11 Billion JPY | 19.45% |
| 2008 | 838.94 Billion JPY | 4.16% |
| 2007 | 805.41 Billion JPY | 4.13% |
| 2006 | 773.44 Billion JPY | 9.48% |
| 2005 | 706.48 Billion JPY | 17.05% |
| 2004 | 603.58 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 373.04 Billion JPY | 4.45% |
| 2023 Q2 | 383.66 Billion JPY | 9.25% |
| 2023 FY | 1476.71 Billion JPY | 6.35% |
| 2023 Q1 | 351.17 Billion JPY | 6.18% |
| 2023 Q4 | 357.16 Billion JPY | -7.16% |
| 2023 Q3 | 384.7 Billion JPY | 0.27% |
| 2022 Q3 | 378.09 Billion JPY | 6.11% |
| 2022 Q2 | 356.32 Billion JPY | 10.18% |
| 2022 Q1 | 323.39 Billion JPY | 2.36% |
| 2022 FY | 1388.56 Billion JPY | 9.67% |
| 2022 Q4 | 330.75 Billion JPY | -12.52% |
| 2021 Q2 | 312.01 Billion JPY | 1.03% |
| 2021 FY | 1266.17 Billion JPY | 4.61% |
| 2021 Q1 | 308.82 Billion JPY | 5.34% |
| 2021 Q3 | 329.37 Billion JPY | 5.56% |
| 2021 Q4 | 315.95 Billion JPY | -4.08% |
| 2020 Q1 | 298.67 Billion JPY | 1.05% |
| 2020 Q2 | 297.32 Billion JPY | -0.45% |
| 2020 Q3 | 321.17 Billion JPY | 8.02% |
| 2020 Q4 | 293.15 Billion JPY | -8.72% |
| 2020 FY | 1210.33 Billion JPY | -4.23% |
| 2019 Q2 | 321.52 Billion JPY | 2.88% |
| 2019 Q4 | 295.56 Billion JPY | -11.55% |
| 2019 FY | 1263.76 Billion JPY | 3.4% |
| 2019 Q1 | 312.52 Billion JPY | 5.94% |
| 2019 Q3 | 334.15 Billion JPY | 3.93% |
| 2018 Q3 | 333.54 Billion JPY | 14.12% |
| 2018 Q4 | 295.01 Billion JPY | -11.55% |
| 2018 FY | 1222.19 Billion JPY | 0.73% |
| 2018 Q1 | 301.34 Billion JPY | 3.96% |
| 2018 Q2 | 292.28 Billion JPY | -3.01% |
| 2017 Q4 | 289.87 Billion JPY | -11.49% |
| 2017 Q3 | 327.48 Billion JPY | 10.38% |
| 2017 Q2 | 296.68 Billion JPY | -0.87% |
| 2017 Q1 | 299.27 Billion JPY | 2.51% |
| 2017 FY | 1213.32 Billion JPY | -1.45% |
| 2016 Q2 | 301.44 Billion JPY | -4.1% |
| 2016 Q3 | 323.46 Billion JPY | 7.3% |
| 2016 FY | 1231.17 Billion JPY | -5.9% |
| 2016 Q4 | 291.93 Billion JPY | -9.75% |
| 2016 Q1 | 314.33 Billion JPY | -7.02% |
| 2015 FY | 1308.35 Billion JPY | 12.58% |
| 2015 Q3 | 368.09 Billion JPY | 19.89% |
| 2015 Q4 | 338.07 Billion JPY | -8.15% |
| 2015 Q2 | 307.02 Billion JPY | 4.02% |
| 2015 Q1 | 295.15 Billion JPY | 3.81% |
| 2014 Q3 | 316.86 Billion JPY | 13.39% |
| 2014 Q4 | 284.33 Billion JPY | -10.27% |
| 2014 FY | 1162.11 Billion JPY | -2.31% |
| 2014 Q1 | 281.47 Billion JPY | -3.18% |
| 2014 Q2 | 279.43 Billion JPY | -0.73% |
| 2013 Q2 | 289.84 Billion JPY | 0.18% |
| 2013 Q4 | 290.73 Billion JPY | -9.06% |
| 2013 FY | 1189.62 Billion JPY | 4.32% |
| 2013 Q1 | 289.32 Billion JPY | 4.08% |
| 2013 Q3 | 319.71 Billion JPY | 10.3% |
| 2012 Q3 | 306.18 Billion JPY | 9.89% |
| 2012 FY | 1140.35 Billion JPY | 2.91% |
| 2012 Q1 | 277.54 Billion JPY | 2.51% |
| 2012 Q2 | 278.63 Billion JPY | 0.39% |
| 2012 Q4 | 277.98 Billion JPY | -9.21% |
| 2011 Q4 | 270.75 Billion JPY | -9.15% |
| 2011 FY | 1108.14 Billion JPY | 4.58% |
| 2011 Q1 | 265.54 Billion JPY | 2.3% |
| 2011 Q2 | 273.81 Billion JPY | 3.11% |
| 2011 Q3 | 298.03 Billion JPY | 8.85% |
| 2010 Q1 | 258.78 Billion JPY | 6.38% |
| 2010 Q4 | 259.57 Billion JPY | -7.34% |
| 2010 FY | 1059.58 Billion JPY | 5.73% |
| 2010 Q3 | 280.14 Billion JPY | 7.31% |
| 2010 Q2 | 261.07 Billion JPY | 0.88% |
| 2009 Q4 | 243.26 Billion JPY | -13.82% |
| 2009 Q1 | 232.9 Billion JPY | 13.8% |
| 2009 Q2 | 243.66 Billion JPY | 4.62% |
| 2009 FY | 1002.11 Billion JPY | 19.45% |
| 2009 Q3 | 282.28 Billion JPY | 15.85% |
| 2008 Q2 | 204.26 Billion JPY | 0.0% |
| 2008 Q3 | 224.86 Billion JPY | 10.08% |
| 2008 Q4 | 204.65 Billion JPY | -8.99% |
| 2008 FY | 838.94 Billion JPY | 4.16% |
| 2007 FY | 805.41 Billion JPY | 4.13% |
| 2006 FY | 773.44 Billion JPY | 9.48% |
| 2005 FY | 706.48 Billion JPY | 17.05% |
| 2004 FY | 603.58 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -2276.16% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 65.366% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | -369.456% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | -239.411% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -18982.847% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | -896.062% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -1949.736% |
| Eisai Co., Ltd. | 741.75 Billion JPY | -99.085% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -11803.208% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | -942.096% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | -1335.303% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -2565.256% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -4702.628% |
| Tsumura & Co. | 150.84 Billion JPY | -878.96% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -1853.865% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -2602.72% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | -547.868% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -3511.514% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | -1850.096% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | -1135.411% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -29199.841% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -3048.975% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -26318.41% |
| MedRx Co., Ltd | 26 Million JPY | -5679561.538% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -13337.194% |
| Solasia Pharma K.K. | 617 Million JPY | -239237.439% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -2249.843% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | -734.952% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -2416302.671% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -6571.647% |